Bluebird’s $2.8 million gene therapy becomes most expensive drug after U.S. approval
Bluebird has been in talks with insurers about a one-time payment option. Bluebird's $2.8 million gene therapy becomes most expensive ...
Bluebird has been in talks with insurers about a one-time payment option. Bluebird's $2.8 million gene therapy becomes most expensive ...